home *** CD-ROM | disk | FTP | other *** search
- From: KELLEY MILEY <KMILEY0A@SAND.LIUNET.EDU>
- Date: Fri, 22 Apr 1994 14:29:24 -0500 (EST)
- Subject: Ecstasy
-
- Due to all the recent interest in Ecstasy, I thought you might find
- this article interesting.
-
- Reprinted without permission from Psycology Today May/June 1994
- Volume 27, No3, pp. 16-17.
-
- Ecstasy - a dose of generation X
-
- For the first time, the FDA has formally approved for research use in
- humans the hallucinogenic agent Ecstasy. Researchers believe that
- Ecstasy, technically known as MDMA, may relieve the pain and
- emotional distress of terminal cancer patients and speed the recovery
- of soldiers suffering from post-traumatic stress disorder.
-
- Dubbed "the love drug" for effects that include profound feelings of
- empathy and a nirvana-like contentment, Ecstasy was outlawed by the
- Drug Enforcement Agency in 1986. But the same effects that have made
- it a popular underground agent make it of interest to psychiatrists
- today. MDMA may acceleralte the therapuetic process of psychotherapy.
-
- "Between 1977 and 1985, roughly half a million doses were
- administered for the treatment of depression, anxiety, rape-related
- trauma, and even schizophrenia," reports Richard Doblin, a doctoral
- student at Harvard University who leads the Multidisciplinary
- Association for Psychedelic Research. He charges that "politics over
- science" stifled proper funding and recognition of MDMA research
- thereafter.
-
- What's more, he laims that in giving the signal for formal research
- on MDMA only now, the FDA has "failed to recognize the successful
- results of the past." So the drug must undergo "lengthy and
- expensive testing in order to establish what we already know -- that
- MDMA is safe for clinical use."
-
- Studies to establish basic human safety, now underway at the
- University of California at Los Angeles by psychiatrist Charles Grob,
- M.D., must be completed before any clinical trials of MDMA can begin.
- The drug's effect on brain chemistry is also being examined.
-
- Ecstasy is know to be safer that LSD, the hallucinogen famed for
- producing psychotic episodes in the '60s. However, there is concern
- about MDMA's effect on the neurotransmitter serotonin, the levels of
- which are closely linked to depression and sleep regulation. In one
- study, heavy MDMA users reportedly experienced a 30 percent decrease
- in serotonin levels. However, they did not experience the impulsive
- and hostile behavior other studies have linked to lowered serotonin
- levels.
-
- -----Paul Glanzrock
-
-
- There is also an insert that reads:
-
- The FDA Opens Its Mind
-
- The FDA has recently approved the research use of a number of other
- psychedelic agents. Observers attribute the loosening up of the
- agency to key personnel changes and pressure from activist groups.
-
- ** Marijuana, for the treatment of epilepsy, Huntington's chorea, and
- appetite loss and psychological trauma in HIV-positive and AIDS
- patients.
-
- ** The African root ibogaine, which has psychedelic properties, to
- reduce dependency in cocaine, heroin, alcohol, and nicotine addiction.
-
- ** Research into LSD as an addiction-busting agent has been resumed.
-
-
- ----------------------------------------------------------------------
- Kelley Miley, Lab Manager
- Long Island University/Southampton College
- kmiley0a@sand.liunet.edu
-
-
-